Form 8-K - Current report:
SEC Accession No. 0001662252-21-000011
Filing Date
2021-07-06
Accepted
2021-07-06 14:23:38
Documents
1
Period of Report
2021-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K rcha8k.htm 8-K 16365
  Complete submission text file 0001662252-21-000011.txt   17605
Mailing Address 145 S. FAIRFAX AVE #200 LOS ANGELES CA 90036
Business Address 145 S. FAIRFAX AVE #200 LOS ANGELES CA 90036 702-825-2254
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | State of Incorp.: WY | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-54767 | Film No.: 211073594
SIC: 2834 Pharmaceutical Preparations